(Q37330696)

19 August 2017

1 reference

title

Impact of conjugate pneumococcal vaccines on antibiotic resistance (English)

1 reference

19 August 2017

antibiotic resistance

1 reference

1 reference

2

Keith P Klugman

1 reference

19 August 2017

1

Ron Dagan

1 reference

19 August 2017

1 December 2008

1 reference

Lancet Infectious Diseases

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

785-795

1 reference

19 August 2017

12

1 reference

Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

A European study on the relationship between antimicrobial use and antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Predicting antimicrobial resistance in invasive pneumococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Nasopharyngeal colonization: a target for pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

The potential indirect effect of conjugate pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Independent risk factors for carriage of penicillin-non-susceptible Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Distribution of the sensitivities to penicillin of types of Diplococcus pneumoniae in an American Indian population.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Changes in frequency and pathogens causing acute otitis media in 1995-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Treatment of acute otitis media - challenges in the era of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Changing trends in antimicrobial-resistant pneumococci: it's not all bad news

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Reduction in antibiotic use among US children, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Decline in inappropriate antibiotic use over a decade by pediatricians in a Tennessee community.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Changes in antibiotic prescribing for children after a community-wide campaign

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Management of febrile children in the conjugate pneumococcal vaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970281-0

7 January 2021

10.1016/S1473-3099(08)70281-0

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19022193